<code id='726F62834A'></code><style id='726F62834A'></style>
    • <acronym id='726F62834A'></acronym>
      <center id='726F62834A'><center id='726F62834A'><tfoot id='726F62834A'></tfoot></center><abbr id='726F62834A'><dir id='726F62834A'><tfoot id='726F62834A'></tfoot><noframes id='726F62834A'>

    • <optgroup id='726F62834A'><strike id='726F62834A'><sup id='726F62834A'></sup></strike><code id='726F62834A'></code></optgroup>
        1. <b id='726F62834A'><label id='726F62834A'><select id='726F62834A'><dt id='726F62834A'><span id='726F62834A'></span></dt></select></label></b><u id='726F62834A'></u>
          <i id='726F62834A'><strike id='726F62834A'><tt id='726F62834A'><pre id='726F62834A'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:44478
          Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill. -- health policy coverage from STAT
          Sen. Ron Wyden, D-Ore., left, and Sen. Mike Crapo, R-Idaho, right, walk on Capitol Hill in 2021. Susan Walsh/AP

          WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT.

          The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase. The committee has jurisdiction over Medicare and Medicaid payment policies for hospitals. Other committees that have tried tackling the issue have jurisdiction mostly over the Food and Drug Administration.

          advertisement

          The panel is tentatively aiming to hold a hearing on the issue in November, the sources said. The panel has also started accepting input from outside stakeholders, one lobbyist said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Orchard's therapy for neuron disease in children wins FDA approval
          Orchard's therapy for neuron disease in children wins FDA approval

          AdobeTheFoodandDrugAdministrationonMondayapprovedagenetherapyformetachromaticleukodystrophy,adevasta

          read more
          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more

          U.K. researchers warn about biases in medical devices, algorithms

          Pulseoximeters,whichtrackbloodoxygenlevels,canoverestimatesuchlevelsinpatientswithdarkerskin,potenti